Increased erythrocyte phosphatidylserine exposure in sickle cell disease: Flow-cytometric measurement and clinical associations

Blood

Volumn 88, Issue 5, 1996, Pages 1873-1880

  Wood, Brent L ^a   Gibson, Donald F ^a   Tait, Jonathan F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; PHOSPHATIDYLSERINE;

ARTICLE; BETA THALASSEMIA; BLOOD CLOTTING; BLOOD TRANSFUSION; CELL ADHESION; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SICKLE CELL; SICKLE CELL ANEMIA;

EID: 0029817966     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.5.1873.1873     Document Type: Article

References (36)

1. Hebbel RP: Beyond hemoglobin polymerization: The red blood cell membrane and sickle disease pathophysiology. Blood 77:214, 1991
2. Lubin B, Vichinsky E: Sickle cell disease, in Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ (eds): Hematology. New York, NY, Churchill Livingstone, 1991, p 450
3. Lubin B, Chiu D, Bastacky J, Roelofsen B, Van Deenen LL: Abnormalities in membrane phospholipid organization in sickled erythrocytes. J Clin Invest 67:1643, 1981
4. Chiu D, Lubin B, Roelofsen B, van Deenen LL: Sickled erythrocytes accelerate clotting in vitro: An effect of abnormal membrane lipid asymmetry. Blood 58:398, 1981
5. Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW: Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: Possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest 65:154, 1980
6. Hebbel RP, Eaton JW, Steinberg MH, White JG: Erythrocyte/ endothelial interactions and the vasocclusive severity of sickle cell disease. Prog Clin Biol Res 55:145, 1981
7. Kalra VK, Banerjee R, Sorgente N: Heterotypic and homotypic cell-cell adhesion molecules in endothelial cells. Biotechnol Appl Biochem 12:579, 1990
8. Schwartz RS, Tanaka Y, Fidler IJ, Chiu DT, Lubin B, Schroit AJ: Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J Clin Invest 75:1965, 1985
9. McEvoy L, Williamson P, Schlegel RA: Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. Proc Natl Acad Sci USA 83:3311, 1986
10. Connor J, Pak CC, Schroit AJ: Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationships to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 269:2399, 1994
11. Sambrano GR, Steinberg D: Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci USA 92:1396, 1995
12. Schroit AJ, Madsen JW, Tanaka Y: In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J Biol Chem 260:5131, 1985
13. Raynal P, Pollard HB: Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium-and phospholipid-binding proteins. Biochim Biophys Acta 1197:63, 1994
14. Thiagarajan P, Tait JF: Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 265:17420, 1990
15. Tait JF, Gibson D: Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J Lab Clin Med 123:741, 1994
16. Thiagarajan P, Tait JF: Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem 266:24302, 1991
17. Dachary Prigent J, Freyssinet JM, Pasquet JM, Carron JC, Nurden AT: Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: A flow cytometry study showing a role for free sulfhydryl groups. Blood 81:2554, 1993
18. Satta N, Toti F, Feugeas O, Bohbot A, Dachary Prigent J, Eschwege V, Hedman H, Freyssinet JM: Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 153:3245, 1994
19. Kojima H, Newton ND, Weiss HJ, Zhao J, Sims PJ, Wiedmer T: Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest 94:2237, 1994
20. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415, 1994
21. Homburg CH, de Haas M, von dem Borne AE, Verhoeven AJ, Reutelingsperger CP, Roos D: Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 85:532, 1995
22. Kuypers FA, Styles L, Yee M, Schott MA, Lubin BH, Vichinsky E: Increased plasma levels of fragment 1.2 correlate with loss of phospholipid asymmetry in subpopulations of sickle cells. Blood 86:298a, 1995 (abstr, suppl 1)
23. Tomer A, Harker LA, Kasey S, Eckman JR: Reduced predisposition to thrombosis in sickle cell disease (SCD) patients treated with dietary n-3 fatty acids (n-3FA). Blood 86:298a, 1995 (abstr, suppl 1)
24. Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, Lubin BH: Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 87:1179, 1996
25. Funakoshi T, Heimark RL, Hendrickson LE, McMullen BA, Fujikawa K: Human placental anticoagulant protein: Isolation and characterization. Biochemistry 26:5572, 1987
26. Tait JF, Smith C: Site-specific mutagenesis of annexin V: Role of residues from Arg-200 to Lys-207 in phospholipid binding. Arch Biochem Biophys 288:141, 1991
27. Tait JF, Gibson D, Fujikawa K: Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 264:7944, 1989
28. Serke S, Huhn D: Identification of CD71 (transferrin receptor) expressing erythrocytes by multiparameter-flow-cytometry (MP-FCM): Correlation to the quantitation of reticulocytes as determined by conventional microscopy and by MP-FCM using a RNA-staining dye. Br J Haematol 81:432, 1992
29. Rao LV, Tait JF, Hoang AD: Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Thromb Res 67:517, 1992
30. Sugimura M, Donato R, Kakkar VV, Scully MF: Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces. Blood Coagul Fibrinolysis 5:365, 1994
31. van Heerde WL, Poort S, van 't Veer C, Reutelingsperger CP, de Groot PG: Binding of recombinant annexin V to endothelial cells: Effect of annexin V binding on endothelial-cell-mediated thrombin formation. Biochem J 302:305, 1994
32. Shohet SB, Beutler E: The red cell membrane, in Williams WJ, Beutler E, Erslev A, Lichtman MA (eds): Hematology (ed 3). New York, NY, McGraw-Hill, 1983, p 345
33. Rosing J, van Rijn JL, Bevers EM, van Dieijen G, Comfurius P, Zwaal RF: The role of activated human platelets in prothrombin and factor X activation. Blood 65:319, 1985
34. Francis RB Jr: Platelets, coagulation, and fibrinolysis in sickle cell disease: Their possible role in vascular occlusion. Blood Coagul Fibrinolysis 2:341, 1991
35. Borenstain Ben Yashar V, Barenholz Y, Hy Am E, Rachmilewitz EA, Eldor A: Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 44:63, 1993
36. Allen TM, Williamson P, Schlegel RA: Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. Proc Natl Acad Sci USA 85:8067, 1988